Insider Trading History of Clark Mitchall G.

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Clark Mitchall G. since 2015. The trader's CIK number is 1612094. At the time of the last reporting, Clark Mitchall G. was the Chief R & QA Officer of Atara Biotherapeutics, Inc.. (stock ticker symbol ATRA). Also see all insider trading activities at Atara Biotherapeutics, Inc..


Yearly summary of insider trading at Atara Biotherapeutics, Inc. (ATRA) by Clark Mitchall G.

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2018 ATRA 0 $0 153,110 $6,293,569 84,773 $1,427,651
2017 ATRA 0 $0 13,243 $197,892 28,846 $0
2016 ATRA 0 $0 11,301 $185,157 28,846 $0
2015 ATRA 0 $0 11,982 $493,146 47,433 $137,068


Insider trading of Atara Biotherapeutics, Inc. (ATRA) by Clark Mitchall G.

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2018-05-18 ATRA Sale 25,860 50.03 1,293,775
2018-05-16 ATRA Sale 4,647 46.17 214,551
2018-05-15 ATRA Option Ex 4,808 .00 0
2018-03-29 ATRA Sale 22,400 40.07 897,568
2018-03-27 ATRA Option Ex 72,754 19.62 1,427,651
2018-03-27 ATRA Sale 100,203 38.80 3,887,675
2018-02-15 ATRA Option Ex 7,211 .00 0
2017-11-15 ATRA Option Ex 7,212 .00 0
2017-11-16 ATRA Sale 3,290 14.20 46,718
2017-08-15 ATRA Option Ex 7,211 .00 0
2017-08-16 ATRA Sale 3,021 14.33 43,290
2017-05-15 ATRA Option Ex 7,212 .00 0
2017-05-16 ATRA Sale 3,873 15.25 59,063
2017-02-15 ATRA Option Ex 7,211 .00 0
2017-02-16 ATRA Sale 3,059 15.96 48,821
2016-11-16 ATRA Sale 2,995 19.53 58,492
2016-11-15 ATRA Option Ex 7,212 .00 0
2016-08-15 ATRA Option Ex 7,211 .00 0
2016-05-16 ATRA Option Ex 7,212 .00 0
2016-05-16 ATRA Sale 4,153 15.15 62,917
2016-02-16 ATRA Sale 4,153 15.35 63,748
2016-02-16 ATRA Option Ex 7,211 .00 0
2015-11-16 ATRA Option Ex 4,808 .00 0
2015-11-16 ATRA Sale 4,153 31.67 131,525
2015-08-17 ATRA Option Ex 11,375 12.05 137,068
2015-08-17 ATRA Sale 7,829 46.19 361,621
2015-05-15 ATRA Option Ex 31,250 .00 0

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Clark Mitchall G. (Chief R & QA Officer of Atara Biotherapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.